Quarterly history
AUM ($B)fundS&P 500(gap = α)/ Flow in/out
Behavior signals (lifetime)
Dip response
-22.71%
trims when stocks drop
when a holding falls −10%+
Middle response
+27.08%
steady accumulation
Rally response
-14.77%
trims into rallies
when a holding rises +10%+
Top positions · 5
| Ticker | $ value | % port | YoY | Hold time |
|---|---|---|---|---|
| BLTEBelite Bio, Inc | $456M | 38.2% | +140.8% | 0.5 yr |
| ABVXAbivax S.A. | $352M | 29.5% | +1681.6% | 0.8 yr |
| RVMDRevolution Medicines, In | $205M | 17.2% | +175.0% | 0.3 yr |
| ROIVRoivant Sciences Ltd. | $180M | 15.0% | +174.5% | 0.3 yr |
| DNTHDianthus Therapeutics, I | $1M | 0.1% | +362.6% | 0.3 yr |
Portfolio composition (YoY)
Industry mix
Biotechnology100.0%+0.0pp$1.19B
Country
US55.5%+49.3pp
FR29.5%
GB15.0%-78.8pp
Top 5: 100.0% · Top 10: 100.0% · Top 25: 100.0%
Winners
| Ticker | Prev $ | PnL | YoY % |
|---|
Losers
| Ticker | Prev $ | PnL | YoY % |
|---|
Quarterly history (TTM returns)
| Period | AUM | # Pos | Return (1yr) | SPY (1yr) | Alpha (1yr) | Flow |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1.19B | 5 | +151.52% | +17.59% | +133.93% | -0.03B |
| 2025-12-31 | $1.30B | 5 | +131.46% | +17.72% | +113.74% | +0.27B |
| 2025-09-30 | $700M | 4 | +18.60% | +17.52% | +1.08% | -0.38B |
| 2025-06-30 | $459M | 4 | -40.44% | +14.94% | -55.38% | +0.26B |
| 2025-03-31 | $262M | 2 | -27.29% | +8.30% | -35.59% | +0.12B |
| 2024-12-31 | $161M | 5 | -9.21% | +24.89% | -34.10% | -0.19B |
| 2024-09-30 | $463M | 4 | +4.98% | +36.04% | -31.06% | -0.27B |
| 2024-06-30 | $622M | 8 | -23.82% | +24.49% | -48.31% | -0.09B |
| 2024-03-31 | $751M | 12 | +13.29% | +29.62% | -16.34% | +0.20B |
| 2023-12-31 | $509M | 8 | +11.45% | +26.18% | -14.73% | +0.26B |
| 2023-09-30 | $284M | 3 | +31.00% | +21.57% | +9.43% | -0.24B |
| 2023-06-30 | $612M | 3 | +40.51% | +8.68% | +31.83% | +0.10B |
| 2023-03-31 | $366M | 4 | +6.47% | +7.46% | -0.98% | +0.19B |
| 2022-12-31 | $161M | 4 | +2.32% | +7.56% | -5.24% | +0.09B |
| 2022-09-30 | $66M | 2 | — | — | — | -0.12B |
| 2022-06-30 | $188M | 1 | — | — | — | +0.08B |